Your session is about to expire
← Back to Search
Telehealth Mental Health Support for Developmental Disabilities
N/A
Recruiting
Led By Joan B Beasley, PhD
Research Sponsored by University of New Hampshire
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participant age 12-45 years
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in feis scores [at 2 timepoints: enrollment, and 1 year (or discharge)]
Awards & highlights
No Placebo-Only Group
Summary
This trial will study if telemental health services can improve access to mental health care for those with intellectual and developmental disabilities, helping to address the disparity in care.
Who is the study for?
This trial is for young individuals aged 14-35 with intellectual and developmental disabilities who live at home with family. They must be new enrollees in the START program within 90 days of joining, and able to give informed consent.
What is being tested?
The study tests telemental health services versus in-person care within the START model, focusing on crisis prevention and intervention for those with IDD. It includes stakeholder feedback, a randomized control trial, and analysis of outcomes across subpopulations.
What are the potential side effects?
Since this trial involves mental health services rather than medication or medical procedures, traditional side effects are not applicable. However, participants may experience varying psychological impacts based on individual responses to telehealth interventions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 12 and 45 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in feis scores [at 2 timepoints: enrollment, and 1 year (or discharge)]
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in feis scores [at 2 timepoints: enrollment, and 1 year (or discharge)]
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Family Experiences Interview Schedule (FEIS) over 1 year
Secondary study objectives
Change in Aberrant Behavior Checklist (ABC) at 1 year
Change in Crisis Service Use at 1 year
Change in mental health stability as measured by START Plan scores at 1 year
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Telemental health STARTExperimental Treatment4 Interventions
Telemental health START will deliver two components via telephonic or other communication technology (e.g., Zoom). This includes component #2 (consultation and coping skills coaching) and component #4 (service linkages, referrals, outreach, \& training). START components #1 (intake and quarterly assessment) and #3 (24-hour urgent crisis response and intervention) will continue to be provided in-person.
Group II: In-person STARTActive Control4 Interventions
In-person START will deliver all model components in-person. This is the established model.
Find a Location
Who is running the clinical trial?
University of FloridaOTHER
1,403 Previous Clinical Trials
763,863 Total Patients Enrolled
University of New HampshireLead Sponsor
15 Previous Clinical Trials
104,993 Total Patients Enrolled
Georgetown UniversityOTHER
350 Previous Clinical Trials
138,664 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- N/AI am between 12 and 45 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Telemental health START
- Group 2: In-person START
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger